These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1256229)

  • 1. [Clinical experimentation with RU 19,(83 (Dabical) calcium clofibrate].
    Pauchant M; Bourbillon JP
    Lille Med; 1976 Jan; 21(1 suppl 1):24-8. PubMed ID: 1256229
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hyperlipidemias by RU 19,583 (Dabical)].
    Creff AF
    Med Chir Dig; 1975; 4(3):197-200. PubMed ID: 1219237
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimentation with Atherulip 500 (apropos of 30 cases)].
    Jaillard J
    Lille Med; 1976 Dec; 21 Suppl 4():915-8. PubMed ID: 1018618
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative double-blind study on the normolipemic effect of clofibrate and a clofibrate-mucopolysaccharide extract combination].
    Cagli V; Lillo V
    Clin Ter; 1975 Oct; 75(2):153-69. PubMed ID: 132333
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of symfibrate in the treatment of hyperlipemias. Preliminary data].
    Giuliani A; Trezzini C; Urbinati G; Conti R
    Clin Ter; 1979 Mar; 88(5):481-9. PubMed ID: 466970
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clofibrate--helpful or harmful?].
    Hartmann G; Micheli H; Mordasini R; Noseda G; Stähelin HB
    Schweiz Med Wochenschr; 1979 Aug; 109(31):1137-9. PubMed ID: 472701
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of long-term treatment of hyperlipemias].
    Reuter W
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:156-9. PubMed ID: 4200339
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of Clofibrate on disorders in lipid metabolism. I].
    Szybiński Z; Lankosz J; Kieta-Fyda A; Bobrowski A; Biczowa N; Mareczek S
    Przegl Lek; 1971 Oct; 28(10):668-71. PubMed ID: 5136016
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term management of various hyperlipidemias using clofibrate].
    Studlar M; Pichler O; Kindler K
    Wien Med Wochenschr; 1975 Dec; 125(50-52):746-51. PubMed ID: 1229130
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of a lipid-reducing clofibrate-inositolnicotinate combination compared to clofibrate. A double-blind study].
    Schäfer B; Kluthe R
    Med Welt; 1975 Apr; 26(14):655-63. PubMed ID: 1099394
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of thiadenol in diabetic hyperdyslipemia as compared with clofibrate].
    Nicrosini F; Pasotti C
    Clin Ter; 1979 Aug; 90(3):241-50. PubMed ID: 553752
    [No Abstract]   [Full Text] [Related]  

  • 14. [From the Adverse Drug Reaction Committee: clofibrate and biliary tract calculi].
    Laake K; Borchgrevink C
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):46. PubMed ID: 1257957
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy of hyperlipidemic states].
    Lipovetskiĭ BM; Triufanov VF; Konstantinov VO
    Klin Med (Mosk); 1980 Apr; 58(4):56-61. PubMed ID: 7382369
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome].
    Fabre J; Denizot M; Wildi E; Micheli H; Berthoud S
    Schweiz Rundsch Med Prax; 1973 Jun; 62(23):732-7. PubMed ID: 4705828
    [No Abstract]   [Full Text] [Related]  

  • 17. [Etamysylate in the treatment of essential hyperlipemia].
    Baiotti G
    Minerva Med; 1973 Oct; 64(71):3709-17. PubMed ID: 4588362
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hyperlipidemias. Value of a new hypolipidemic drug clofibride, (M-G. 46)].
    Leutenegger M; Choisy H; Caron J; Paris H
    Therapie; 1974; 29(4):599-610. PubMed ID: 4439371
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the spectrum of serum lipids following 3 months administration of clofibrate Spofa].
    Cagánova A; Cagan S
    Cesk Farm; 1971 Nov; 20(9):341-6. PubMed ID: 5136172
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic of acetiromate on hyperlipidemia--comparison with clofibrate using a double-blind method].
    Nakano Y; Fukui I; Niiho S; Kuki H; Takahata J
    Nihon Rinsho; 1974 Jul; 32(7):2526-51. PubMed ID: 4612204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.